Similar articles

• Thalidomide in Crohn disease and the risk of peripheral neuropathy.

  Ahmed M, El-Hadi S, Jenkins HR. Ahmed M, et al. J Pediatr Gastroenterol Nutr. 2003 Oct;37(4):522. doi: 10.1097/00005176-200310000-00023. J Pediatr Gastroenterol Nutr. 2003. PMID: 14508228 No abstract available.
• Thalidomide in Crohn disease.

  Pigott A, Casson D. Pigott A, et al. J Pediatr Gastroenterol Nutr. 2005 Feb;40(2):236. doi: 10.1097/00005176-200502000-00035. J Pediatr Gastroenterol Nutr. 2005. PMID: 15699709 No abstract available.
• Longitudinal Patterns of Thalidomide Neuropathy in Children and Adolescents.

  Liew WK, Pacak CA, Visyak N, Darras BT, Bousvaros A, Kang PB. Liew WK, et al. J Pediatr. 2016 Nov;178:227-232. doi: 10.1016/j.jpeds.2016.07.040. Epub 2016 Aug 24. J Pediatr. 2016. PMID: 27567409
• Thalidomide in ankylosing spondylitis.

  Huang F, Wei JC, Breban M. Huang F, et al. Clin Exp Rheumatol. 2002 Nov-Dec;20(6 Suppl 28):S158-61. Clin Exp Rheumatol. 2002. PMID: 12463469 Review.
• Thalidomide-induced sinus bradycardia in Crohn's disease: case report and literature review.

  Liu M, Lin X, Wang L, He Y, Chen M, Mao R. Liu M, et al. J Int Med Res. 2019 May;47(5):2228-2233. doi: 10.1177/0300060519833293. Epub 2019 Mar 5. J Int Med Res. 2019. PMID: 30832535 Free PMC article. Review.